Cannabis Shows Promise for Autoimmune Diseases, but Evidence Remains Thin
A review found encouraging perspectives on cannabis for autoimmune and rheumatic conditions, but noted the evidence remains insufficient and needs validation through rigorous clinical trials.
Quick Facts
What This Study Found
Cannabis-based treatments show potential benefits across various autoimmune and rheumatic conditions, but in many cases the supporting evidence is insufficient. Social and legal barriers have hindered the rigorous clinical trials needed to validate these findings.
Key Numbers
Review covers multiple autoimmune and rheumatic conditions; specific outcome data from individual studies cited in full text.
How They Did This
Review of updated data on cannabis-based treatments for autoimmune and rheumatic conditions including their potential therapeutic roles.
Why This Research Matters
Autoimmune diseases affect millions and current treatments often have significant side effects. If cannabis-based therapies prove effective, they could offer a complementary or alternative approach.
The Bigger Picture
The endocannabinoid system plays a documented role in immune regulation, providing a biological rationale for cannabis in autoimmune conditions. However, the gap between biological plausibility and clinical proof remains wide.
What This Study Doesn't Tell Us
Evidence base is largely preclinical or from small studies. Regulatory and legal barriers have prevented large-scale clinical trials. Optimal formulations, doses, and cannabinoid combinations unknown.
Questions This Raises
- ?Which autoimmune conditions are most likely to benefit from cannabis treatment?
- ?Can cannabis reduce the need for conventional immunosuppressants?
- ?What role does the route of administration play?
Trust & Context
- Key Stat:
- Cannabis shows promise for autoimmune conditions but evidence remains insufficient for clinical use
- Evidence Grade:
- Review identifies encouraging trends but explicitly acknowledges the evidence is insufficient for clinical recommendations.
- Study Age:
- 2025 review capturing current state of cannabis-autoimmune research.
- Original Title:
- Exploring therapeutic potential of Cannabis based therapy in autoimmune and rheumatic disorders.
- Published In:
- Autoimmunity reviews, 24(12), 103925 (2025)
- Database ID:
- RTHC-07133
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can cannabis help with autoimmune diseases?
There are encouraging signs from preclinical research and small studies, but this review emphasizes that the evidence is not yet strong enough to make clinical recommendations. Larger trials are needed.
Why is there so little evidence on cannabis for autoimmune conditions?
Social stigma and legal barriers in many countries have made it difficult to conduct the rigorous clinical trials needed. Cannabis's regulatory status has historically impeded research funding and access.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07133APA
Michaeli, Inbar; Lassman, Simon; Halpert, Gilad; Jacob, Giris; Amital, Howard. (2025). Exploring therapeutic potential of Cannabis based therapy in autoimmune and rheumatic disorders.. Autoimmunity reviews, 24(12), 103925. https://doi.org/10.1016/j.autrev.2025.103925
MLA
Michaeli, Inbar, et al. "Exploring therapeutic potential of Cannabis based therapy in autoimmune and rheumatic disorders.." Autoimmunity reviews, 2025. https://doi.org/10.1016/j.autrev.2025.103925
RethinkTHC
RethinkTHC Research Database. "Exploring therapeutic potential of Cannabis based therapy in..." RTHC-07133. Retrieved from https://rethinkthc.com/research/michaeli-2025-exploring-therapeutic-potential-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.